What combined oral contraceptive regimen is appropriate for a healthy 23‑year‑old woman without contraindications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Combined Oral Contraceptive for a Healthy 23-Year-Old Woman

Start with a low-dose monophasic combined oral contraceptive containing 30-35 μg ethinyl estradiol plus levonorgestrel or norgestimate, which can be initiated same-day without a pelvic exam—only blood pressure measurement is required. 1, 2, 1

First-Line Regimen

For a healthy 23-year-old without contraindications, the evidence strongly supports:

  • Ethinyl estradiol 30-35 μg combined with either:
    • Levonorgestrel, or
    • Norgestimate
  • Monophasic formulation (same hormone dose in each active pill) 1, 2

This recommendation prioritizes safety and efficacy. Pills containing ≤35 μg ethinyl estradiol are considered "low-dose" and minimize thromboembolic risk while maintaining contraceptive effectiveness 2, 1. Levonorgestrel and norgestimate are well-studied progestins with favorable safety profiles 1, 3.

Initiation Protocol

Same-day "quick start" is recommended 1:

  • No pelvic examination needed 2, 1
  • Only blood pressure measurement required before prescribing 4
  • If started within 5 days of menses: no backup contraception needed
  • If started >5 days after menses: use backup contraception (condoms or abstinence) for 7 days 4

Absolute Contraindications to Screen For

Before prescribing, ensure she does NOT have 2, 1, 5:

  • Migraine with aura or focal neurologic symptoms
  • Uncontrolled hypertension (≥160/100 mmHg)
  • History of venous thromboembolism or known thrombophilia
  • Current or history of stroke or ischemic heart disease
  • Active liver disease or liver tumor
  • Current breast cancer
  • Smoking ≥15 cigarettes/day if ≥35 years old (not applicable at age 23)

At age 23, smoking is NOT a contraindication to COC use 2, 6.

Practical Prescribing Details

  • Prescribe up to 1 year supply at initial visit 2
  • Schedule follow-up at 1-3 months to address side effects or adherence 2, 1
  • Choose the formulation with lowest copay on her insurance if multiple options meet criteria 1
  • Standard 28-day packs: 21-24 active pills, 4-7 placebo pills 1

Counseling on Common Side Effects

Inform her that these effects are typically transient 2, 1:

  • Irregular bleeding (most common initially)
  • Headache
  • Nausea
  • Weight gain and mood changes are NOT reliably linked to COCs 1

Thromboembolic Risk Context

The absolute risk remains low 2, 1:

  • Baseline VTE risk in young women: 1 per 10,000 woman-years
  • COC use increases risk to: 3-4 per 10,000 woman-years
  • Pregnancy carries higher VTE risk: 10-20 per 10,000 woman-years 2, 1

Missed Pill Instructions

Provide clear guidance 1:

  • One pill missed (<48 hours): Take missed pill immediately, continue as usual
  • Two or more pills missed (≥48 hours):
    • Take most recent missed pill (discard others)
    • Use backup contraception for 7 consecutive days
    • If missed in week 3 (days 15-21): skip placebo week, start new pack immediately
    • Consider emergency contraception if missed in week 1 with recent unprotected intercourse

Non-Contraceptive Benefits

Counsel on additional health benefits 1, 7:

  • Decreased menstrual cramping and blood loss
  • Improvement in acne
  • Protection against endometrial and ovarian cancer (with >3 years use)
  • Reduced risk of ovarian cysts
  • Treatment of dysmenorrhea and endometriosis symptoms

Alternative Considerations

If she prefers fewer periods, extended-cycle regimens may be appropriate after establishing tolerance on standard cycling 1. The contraceptive vaginal ring (15 μg ethinyl estradiol/120 μg etonogestrel) offers comparable efficacy with simpler dosing but is not typically first-line 1.

COCs are completely reversible with no negative effect on long-term fertility 1.

References

Guideline

contraception for adolescents.

Pediatrics, 2014

Guideline

contraception for adolescents.

Pediatrics, 2014

Research

Choosing a combined oral contraceptive pill.

Australian prescriber, 2015

Guideline

u.s. selected practice recommendations for contraceptive use, 2024.

MMWR Recommendations and Reports, 2024

Guideline

guidelines of care for the management of acne vulgaris.

Journal of the American Academy of Dermatology, 2024

Guideline

u s. medical eligibility criteria for contraceptive use, 2010.

MMWR Recommendations and Reports, 2010

Research

Health benefits of combined oral contraceptives - a narrative review.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.